81
74
Growth Score 81 in past quarter
-5 pts
Heat Score 74 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
397743
METHYS Dx develops methylation marker panels for ctDNA characterization in liquid biopsies, focusing on non-invasive cancer monitoring.
About the Company
METHYS Dx develops panels of methylation markers to characterize circulating tumor DNA (ctDNA) within liquid biopsies. The company focuses on personalized medicine in oncology, providing non-invasive tests for cancer patient monitoring. These innovative liquid biopsy tests help in the early detection and monitoring of cancer, offering a less
invasive alternative to traditional biopsy methods.